(Q44861728)

6 December 2017

Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether (English)

1 reference

6 December 2017

0 references

Plasmodium falciparum

0 references

author name string

Stephen Toovey

series ordinal

1

1 reference

PubMed ID

15109547

6 December 2017

Andrew Jamieson

series ordinal

2

1 reference

6 December 2017

1 May 2004

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

6 December 2017

1 reference

6 December 2017

98

1 reference

6 December 2017

261-7; discussion 268-9

1 reference

6 December 2017

5

1 reference

Fatal neurotoxicity of arteether and artemether

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Neurotoxicity in animals due to arteether and artemether.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Chloroquine ototoxicity: an idiosyncratic phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Neuropathological assessment of artemether-treated severe malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Artemether in severe malaria--still too many deaths.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Audiometry as a possible indicator of quinine plasma concentration during treatment of malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Atovaquone and azithromycin for the treatment of babesiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Ataxia and slurred speech after artesunate treatment for falciparum malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Studies of the neurotoxicity of oral artemisinin derivatives in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Neuropathologic toxicity of artemisinin derivatives in a mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Assessment of the neurotoxicity of oral dihydroartemisinin in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

CNS adverse events associated with antimalarial agents. Fact or fiction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Quinine induces reversible high-tone hearing loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Ototoxic reactions of quinine in healthy persons and patients with Plasmodium falciparum infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Co-artemether has been used in ambulatory treatment of falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

The potential of artemether for the control of schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Neurological dysfunction following malaria: disease- or drug-related?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Averting a malaria disaster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Potential long-term toxicity of repeated orally administered doses of artemether in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2003.11.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSTMH.2003.11.001

1 reference

6 December 2017

1 reference

PubMed ID

15109547